BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16638502)

  • 21. Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects.
    Joulia-Ekaza D; Cabello G
    Exp Cell Res; 2006 Aug; 312(13):2401-14. PubMed ID: 16793037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene.
    Grobet L; Pirottin D; Farnir F; Poncelet D; Royo LJ; Brouwers B; Christians E; Desmecht D; Coignoul F; Kahn R; Georges M
    Genesis; 2003 Apr; 35(4):227-38. PubMed ID: 12717734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
    Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
    J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle growth after postdevelopmental myostatin gene knockout.
    Welle S; Bhatt K; Pinkert CA; Tawil R; Thornton CA
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E985-91. PubMed ID: 17148752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cDNA encoding sequences for myostatin and FGF6 in sea bass (Dicentrarchus labrax, L.) and the effect of fasting and refeeding on their abundance levels.
    Terova G; Bernardini G; Binelli G; Gornati R; Saroglia M
    Domest Anim Endocrinol; 2006 May; 30(4):304-19. PubMed ID: 16183242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged absence of myostatin reduces sarcopenia.
    Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
    J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postexercise myostatin and activin IIb mRNA levels: effects of strength training.
    Hulmi JJ; Ahtiainen JP; Kaasalainen T; Pöllänen E; Häkkinen K; Alen M; Selänne H; Kovanen V; Mero AA
    Med Sci Sports Exerc; 2007 Feb; 39(2):289-97. PubMed ID: 17277593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myostatin is a procachectic growth factor during postnatal myogenesis.
    McFarlane C; Sharma M; Kambadur R
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):422-7. PubMed ID: 18542002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice.
    Tang L; Yan Z; Wan Y; Han W; Zhang Y
    Muscle Nerve; 2007 Sep; 36(3):342-8. PubMed ID: 17587222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
    Wójcik S; Engel WK; McFerrin J; Askanas V
    Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases.
    Tobin JF; Celeste AJ
    Curr Opin Pharmacol; 2005 Jun; 5(3):328-32. PubMed ID: 15907921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myofibrillar protein synthesis in myostatin-deficient mice.
    Welle S; Bhatt K; Pinkert CA
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E409-15. PubMed ID: 16219664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting.
    García PS; Cabbabe A; Kambadur R; Nicholas G; Csete M
    Anesth Analg; 2010 Sep; 111(3):707-9. PubMed ID: 20686014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myostatin blockade therapy for muscular atrophy].
    Sunada Y
    Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice.
    Matsakas A; Foster K; Otto A; Macharia R; Elashry MI; Feist S; Graham I; Foster H; Yaworsky P; Walsh F; Dickson G; Patel K
    Neuromuscul Disord; 2009 Jul; 19(7):489-99. PubMed ID: 19541486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology.
    Bogdanovich S; Perkins KJ; Krag TO; Whittemore LA; Khurana TS
    FASEB J; 2005 Apr; 19(6):543-9. PubMed ID: 15791004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
    Matsakas A; Diel P
    Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass.
    Kinouchi N; Ohsawa Y; Ishimaru N; Ohuchi H; Sunada Y; Hayashi Y; Tanimoto Y; Moriyama K; Noji S
    Gene Ther; 2008 Aug; 15(15):1126-30. PubMed ID: 18323791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.